1. Home
  2. NB vs MDXG Comparison

NB vs MDXG Comparison

Compare NB & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NB
  • MDXG
  • Stock Information
  • Founded
  • NB 1987
  • MDXG 2006
  • Country
  • NB United States
  • MDXG United States
  • Employees
  • NB N/A
  • MDXG N/A
  • Industry
  • NB Metal Mining
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • NB Basic Materials
  • MDXG Health Care
  • Exchange
  • NB Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • NB 930.8M
  • MDXG 1.0B
  • IPO Year
  • NB N/A
  • MDXG N/A
  • Fundamental
  • Price
  • NB $6.08
  • MDXG $7.96
  • Analyst Decision
  • NB Strong Buy
  • MDXG Buy
  • Analyst Count
  • NB 4
  • MDXG 1
  • Target Price
  • NB $5.75
  • MDXG $12.00
  • AVG Volume (30 Days)
  • NB 13.8M
  • MDXG 1.0M
  • Earning Date
  • NB 11-06-2025
  • MDXG 10-29-2025
  • Dividend Yield
  • NB N/A
  • MDXG N/A
  • EPS Growth
  • NB N/A
  • MDXG N/A
  • EPS
  • NB N/A
  • MDXG 0.27
  • Revenue
  • NB N/A
  • MDXG $393,442,000.00
  • Revenue This Year
  • NB N/A
  • MDXG $19.01
  • Revenue Next Year
  • NB N/A
  • MDXG $2.36
  • P/E Ratio
  • NB N/A
  • MDXG $29.47
  • Revenue Growth
  • NB N/A
  • MDXG 14.77
  • 52 Week Low
  • NB $1.30
  • MDXG $5.79
  • 52 Week High
  • NB $12.58
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • NB 39.55
  • MDXG 72.55
  • Support Level
  • NB $6.89
  • MDXG $6.68
  • Resistance Level
  • NB $8.16
  • MDXG $7.89
  • Average True Range (ATR)
  • NB 0.87
  • MDXG 0.31
  • MACD
  • NB -0.40
  • MDXG 0.13
  • Stochastic Oscillator
  • NB 1.98
  • MDXG 99.31

About NB NioCorp Developments Ltd.

NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: